#mannkind
Latest news and interesting information about mannkind.
FDA OKs Inhaled Insulin for Kids
FDA approved MannKind's inhaled insulin Afrezza for children aged 6+ with diabetes. Needle-free option offers new hope for young patients.
MannKind shareholders elect directors
MannKind shareholders elect directors, approve executive pay, and ratify auditor at annual meeting. Q1 revenue rose 15% to $90M.
...